About
Kidney-targeted peptide that prevents regulated cell death and kidney failure
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
72
By Phase
NA: 2
By Status
COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06234930Lead Sponsor
The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation
NACompleted
27 participants
Started: Jul 11, 2024 · Completed: Mar 14, 2025
NCT02828722Lead Sponsor
Proof of Concept Trial to Confirm That the Recovery of Patients Treated in the Intensive Care Unit Requiring Mechanical Ventilation is Beneficially Affected by the Environmental Simulation of Daytime and Night Time Alternation as Well as by the Nutrition Protocol Corresponding to the Daily Rhythm
NAUnknown
45 participants
Started: Nov 30, 2016 · Completed: Jun 30, 2017
Locations (1)
Headquarters
Kanata, ON, Canada
Map
Loading map...